109 related articles for article (PubMed ID: 4710096)
1. Studies in the imidazo(1,5-a)pyrazine system.
Abushanab E; Bindra AP; Goodman L; Peterson H
J Org Chem; 1973 Jun; 38(71):2049-52. PubMed ID: 4710096
[No Abstract] [Full Text] [Related]
2. [Studies on pyrazine derivatives. XV. Synthesis and tuberculostatic effect of imidazoline pyrazines and imidazoline pyridines].
Foks H; Janowiec M
Acta Pol Pharm; 1982; 39(1-3):79-82. PubMed ID: 6817592
[No Abstract] [Full Text] [Related]
3. The synthesis of 5,6-dimethyl-1-(beta-D-ribofuranosyl)imidazo(4,5-b)pyrazine by ring closure of an imidazole nucleoside, a new bicyclic nucleoside.
Panzica RP; Townsend LB
Tetrahedron Lett; 1970 Mar; (13):1013-5. PubMed ID: 5439232
[No Abstract] [Full Text] [Related]
4. [SCA 40 and derivatives: new bronchodilators in an imidazo(1,2-a)pyrazine series].
Bonnet PA; Vitse O; Bénezech V; Subra G; Fabréguettes JR; Zanik L; Laurent F; Michel A; Bompart J; Chapat JP
Ann Pharm Fr; 1998; 56(4):155-9. PubMed ID: 9770008
[TBL] [Abstract][Full Text] [Related]
5. Palladium-catalyzed direct heck arylation of dual pi-deficient/pi-excessive heteroaromatics. Synthesis of C-5 arylated imidazo[1,5-a]pyrazines.
Wang JX; McCubbin JA; Jin M; Laufer RS; Mao Y; Crew AP; Mulvihill MJ; Snieckus V
Org Lett; 2008 Jul; 10(14):2923-6. PubMed ID: 18576663
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in development of imidazo[1,2-a]pyrazines: synthesis, reactivity and their biological applications.
Goel R; Luxami V; Paul K
Org Biomol Chem; 2015 Mar; 13(12):3525-55. PubMed ID: 25563506
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of imidazo (4,5-b)pyrazine nucleosides.
Panzica RP; Townsend LB
J Chem Soc Perkin 1; 1973; 3():244-8. PubMed ID: 4736246
[No Abstract] [Full Text] [Related]
8. Synthesis and c-Src inhibitory activity of imidazo[1,5-a]pyrazine derivatives as an agent for treatment of acute ischemic stroke.
Mukaiyama H; Nishimura T; Kobayashi S; Ozawa T; Kamada N; Komatsu Y; Kikuchi S; Oonota H; Kusama H
Bioorg Med Chem; 2007 Jan; 15(2):868-85. PubMed ID: 17095233
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of imidazo[1,2-a]pyridines: "water-mediated" hydroamination and silver-catalyzed aminooxygenation.
Chandra Mohan D; Nageswara Rao S; Adimurthy S
J Org Chem; 2013 Feb; 78(3):1266-72. PubMed ID: 23289894
[TBL] [Abstract][Full Text] [Related]
10. Antiulcer agents. 3. Structure-activity-toxicity relationships of substituted imidazo[1,2-a]pyridines and a related imidazo[1,2-a]pyrazine.
Kaminski JJ; Perkins DG; Frantz JD; Solomon DM; Elliott AJ; Chiu PJ; Long JF
J Med Chem; 1987 Nov; 30(11):2047-51. PubMed ID: 3669012
[TBL] [Abstract][Full Text] [Related]
11. Palladium catalyzed one-pot sequential Suzuki cross-coupling-direct C-H functionalization of imidazo[1,2-a]pyrazines.
Gembus V; Bonfanti JF; Querolle O; Jubault P; Levacher V; Hoarau C
Org Lett; 2012 Dec; 14(23):6012-5. PubMed ID: 23151283
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antibronchospastic activity of 8-alkoxy- and 8-(alkylamino)imidazo[1,2-a]pyrazines.
Bonnet PA; Michel A; Laurent F; Sablayrolles C; Rechencq E; Mani JC; Boucard M; Chapat JP
J Med Chem; 1992 Sep; 35(18):3353-8. PubMed ID: 1527785
[TBL] [Abstract][Full Text] [Related]
13. Potency switch between CHK1 and MK2: discovery of imidazo[1,2-a]pyrazine- and imidazo[1,2-c]pyrimidine-based kinase inhibitors.
Meng Z; Ciavarri JP; McRiner A; Zhao Y; Zhao L; Reddy PA; Zhang X; Fischmann TO; Whitehurst C; Arshad Siddiqui M
Bioorg Med Chem Lett; 2013 May; 23(10):2863-7. PubMed ID: 23587425
[TBL] [Abstract][Full Text] [Related]
14. 2- and 3-substituted imidazo[1,2-a]pyrazines as inhibitors of bacterial type IV secretion.
Sayer JR; Walldén K; Pesnot T; Campbell F; Gane PJ; Simone M; Koss H; Buelens F; Boyle TP; Selwood DL; Waksman G; Tabor AB
Bioorg Med Chem; 2014 Nov; 22(22):6459-70. PubMed ID: 25438770
[TBL] [Abstract][Full Text] [Related]
15. Imidazo[1,2-a]pyrimidines and imidazo[1,2-a]pyrazines: the role of nitrogen position in inotropic activity.
Spitzer WA; Victor F; Pollock GD; Hayes JS
J Med Chem; 1988 Aug; 31(8):1590-5. PubMed ID: 3397997
[TBL] [Abstract][Full Text] [Related]
16. Bioisosteric approach to the discovery of imidazo[1,2-a]pyrazines as potent Aurora kinase inhibitors.
Meng Z; Kulkarni BA; Kerekes AD; Mandal AK; Esposite SJ; Belanger DB; Reddy PA; Basso AD; Tevar S; Gray K; Jones J; Smith EB; Doll RJ; Siddiqui MA
Bioorg Med Chem Lett; 2011 Jan; 21(1):592-8. PubMed ID: 21075632
[TBL] [Abstract][Full Text] [Related]
17. [Synthesis of cypridina luciferin and related compounds. V. On the structure of imidazo[1,2-a]pyrazine derivatives].
Sugiura S; Inoue S; Goto T
Yakugaku Zasshi; 1970 Apr; 90(4):431-5. PubMed ID: 5463472
[No Abstract] [Full Text] [Related]
18. Access to novel imidazo[1,5-a]pyrazine scaffolds by the combined use of a three-component reaction and a base-assisted intramolecular cyclization.
Attanasi OA; Favi G; Giorgi G; Majer R; Perrulli FR; Santeusanio S
Org Biomol Chem; 2014 Jul; 12(26):4610-9. PubMed ID: 24848196
[TBL] [Abstract][Full Text] [Related]
19. [Pyrazine-2-carboxylic acid N-oxides. IV. Reaction of pyrazine-2-carboxamide 4-N-oxide with phosphorus oxycholoride].
Foks H
Acta Pol Pharm; 1976; 33(2):153-61. PubMed ID: 180752
[No Abstract] [Full Text] [Related]
20. Synthesis of imidazo[1,2-a]pyrazine derivatives with uterine-relaxing, antibronchospastic, and cardiac-stimulating properties.
Sablayrolles C; Cros GH; Milhavet JC; Rechenq E; Chapat JP; Boucard M; Serrano JJ; McNeill JH
J Med Chem; 1984 Feb; 27(2):206-12. PubMed ID: 6319701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
